Towercrest Capital Management Spdr Ser Tr Spdr S&P Biotech E Transaction History

Towercrest Capital Management

  • $599 Million
  • Q1 2024

A detailed history of Towercrest Capital Management transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Towercrest Capital Management holds 5,050 shares of XBI stock, worth $461,368. This represents 0.08% of its overall portfolio holdings.

Number of Shares
5,050
Previous 5,050 -0.0%
Holding current value
$461,368
Previous $450,000 6.44%
% of portfolio
0.08%
Previous 0.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$71.88 - $85.76 $362,994 - $433,088
5,050 New
5,050 $368,000
Q1 2019

May 15, 2019
SELL
N/A
-8,750 Closed
0 $0
Q4 2018

Feb 15, 2019
BUY
N/A
8,750 New
8,750 $628,000

Others Institutions Holding XBI

# of Institutions
920
Shares Held
99.8M
Call Options Held
24.7M
Put Options Held
43.4M
View Full List

About SPDR SER TR SPDR S&P BIOTECH E

XBI Quotes by TradingView
  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track This Portfolio

Track Towercrest Capital Management Portfolio

Follow Towercrest Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Towercrest Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Towercrest Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email